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Introduction
Sickle Cell Disease afflicts up to 100 million people 
worldwide, predominantly black people (in Africa, Europe 
and the America), Arabs, and those of  Asian ancestry.1 
In Nigeria, it is estimated that about 150,000 children 
are born with Sickle Cell Anaemia (SCA) annually, with 
a prevalence of  20 - 30 per 1000 live births, (i.e. 2 - 3%) 
while that of  Haemoglobin SC is approximately 0.7%.2,3 
In developed countries such as Europe and America, 
both clinical and epidemiologic data have shown that 
the rates and costs of  hospitalization, emergency 
department (ED) and outpatient visits by this group of  
children are substantial.4-6
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However, in most developing economy like Nigeria, 
there is paucity of  data on its cost of  care and the 
financial burden of  this disease on the family of  the 
affected children and the National health services. 
In Africa, about 230,000 children are born with SCA 
each year, representing about 80 percent of  the global 
burden of  SCA.7 The disease account for more than 
six percent of  all deaths in African children younger 
than five years.8 Most of  the infant deaths due to SCA 
in Africa occur in West African countries, with Nigeria 
alone accounting for about 80 percent of  these deaths.2 
In most developing countries, resources to cater for 
SCA are inadequate, inaccessible and costly when 
available.9,10 This invariably contribute to the relatively 
high morbidities and mortality associated with SCA in 
these environments. 
Estimating the rate and cost of  hospitalizations 
associated with sickle cell disease will therefore form 
the basis for developing appropriate advocacy and 
interventions to limiting SCA complications and 
hospitalizations. Also, it will help in designing evidence-
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based health programs such as health care financing 
and social insurance schemes which in turn will reduce 
the financial burden of  the disease on families. 
Methods
The study was carried out at the Paediatric wards of  the 
Ekiti State Teaching Hospital, Ado-Ekiti, Ekiti State, 
Nigeria. The hospital is a tertiary health institution 
and is the main referral facility providing both general 
and specialist paediatric care for many communities 
of  south-western Nigeria. It is privately funded health 
institution in which patients have to pay for all categories 
of  health care needs. 
This descriptive cross-sectional study was carried out 
over a year (January to December, 2012). We serially 
documented all admissions into the paediatric wards of  
the hospital during the study period and studied all the 
sickle cell disease-related admissions. All the consecutive 
caregivers of  sickle cell anaemic children up to the age 
of  15 years with haemoglobin genotype SS who were 
admitted at the paediatric wards of  the hospital during 
the study period were assessed with semi structured, 
interviewer-administered questionnaires, after obtaining 
an informed consent from the caregiver. Consent was 
obtained for each admission. Ethical clearance was also 
obtained from the Ethics and Research Committee of  
the hospital. 
The questionnaire was used to obtain information on the 
sociodemographic characteristics of  the children such 
as the age, sex, parental socioeconomic class and the 
aggregate family’s monthly income. The socioeconomic 
class was determined based on the occupation and the 
highest level of  educational attainment of  the parents, 
as recommended by Oyedeji.11 For instance, parents 
who are professionals with tertiary education are in 
class I, while unemployed or those doing menial jobs 
with no formal eduaction are in class V. The five classes, 
ranging from I to V which were generated initially were 
later subclassified into three major social classes, namely 
upper class (I and II), middle class (III) and lower class 
(IV and V). 
The principal diagnosis, number of  hospitalisations 
during the study period and the length of  stay (in 
Table I: The detailed socio-demographic characteristics of  the 73 children
Socio-demographic variables
Number of  
children
Pe r c e n t a g e 
(%)
Age in years
        <1 9 12.3
        1 – 5 31 42.5
        6 -10 22 30.1
        11 – 15 11 15.1
Sex
        Male 28 38.4
        Female 45 61.6
Social class#
       Upper class (I and II) 19 26.1
       Middle class (III) 15 20.5
       Lower (IV and V) 39 53.4
Estimated aggregate monthly 
income levels
 <National Minimum wage* 46 63.0
  Below Poverty threshold** 24 32.9
Income quartile
        1st 22 30.1
        2nd 18 24.7
        3rd 19 26.0
        4th 14 19.2
* National Minimum wage in Nigeria as at 2012 was 120 USD                                            
 **Poverty threshold is equivalent to 1.25USD                                                                                     
 # Social class was determined from the parental occupation and their highest level of  educational attainment.
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days) during each hospitalisation were also obtained. 
We derived cost estimates by direct questioning and 
inspection of  receipts obtained for each payment. Cost 
of  hospitalisation included costs of  investigations, drugs, 
blood transfusion, transportation, hospital records, 
surgeries and other hospital services such as consultation, 
nursing care, feeding and accommodation. These costs 
of  hospitalization were added together to calculate cost 
of  care per hospitalization. The total annual cost of  
care, i.e. annual costs for all hospitalisations; average cost 
of  care per hospitalization; aggregate family’s annual 
income and the percentage of  the aggregate annual 
family income spent on hospitalisation were computed. 
Aggregate family income, i.e. the total income realised 
by the family, was determined by adding salaries/wages, 
monetary gifts and other incomes as described by the 
caregiver. Expenditure was calculated in United States 
Dollars, USD (exchange rate at the time of  the study 
was 155 Nigeria Naira per USD). The principal source 
of  funds for each patient was also noted. We categorized 
these sources as “self-pay” (i.e. out-of-pocket) and 
National Health Insurance Scheme (NHIS). 
Data were analysed with SPSS 17.0. Simple descriptive 
and inferential statistics were performed and results 
presented in prose and tables. The proportion of  annual 
income spent as total expenditure on care was expressed 
in percentages. The Effects of  sociodemographic 
variables, rates and duration of  admission on the 
costs of  hospitalization were determined using one-
way ANOVA and independent ‘t’ tests. P value < 0.05 
was taken as statistical significance at 95% confidence 
interval.
Results
Socio-demographic characteristics of  the children 
A total of  73 SCA children were admitted during the 
study period. Their ages ranged from 6 to 180 months, 
with a mean (SD) of  61.1 ± 44.3 months. There were 
nine (12.3%) infants among them. The male to female 
ratio was 1: 1.6. 
Socio-economic status of  the caregivers
Majority, 39 (53.4%) were from the lower social classes 
(IV - V), and only 19 (26.0%) were from the upper 
social classes (I and II). The monthly income of  the 
caregivers ranged from $9.68 to $1,632.26, with mean 
(SD) of  $250.37 ± $272.92. Table I  shows the detailed 
socio-demographic characteristics of  the children. 
About two-third, (63.0%) of  the subjects’ families 
earned below the national monthly minimum wage of  
$120, and about one-third, (32.9%) were living below 
poverty threshold of  1.25USD per day. 
Table II: The detailed rates and duration of  hospitalization of  the SCA children.




Number of  hospitalization 
per year
              Once 31 42.5
              Twice 16 21.9
              Thrice 8 11.0
              >Thrice 18 24.7
Duration of  hospitalization 
              <3 days 6 8.2
              3 – 6 days 18 24.7
              1week – 1 month 45 61.6
              >1 month 4 5.5
Rates and duration of  hospitalization of  SCA 
children 
The 73 SCA children had a total of  183 admissions, 
with rate ranging from one to eight and mean (SD) 
of  2.5 ± 1.9 admissions per child. The median 
hospitalization rate was 2. More than half  of  the 
subjects were admitted more than once and about one 
quarter was admitted more than three times in the 12 
months period of  study as shown in Table II.
The average length of  stay on admission was 7.8 ± 
3.1 days per child per admission (per year), and a total 
of  1056 days of  care per year. The length of  stay 
ranged from one to 52 days; and about two-third of  
the children [49 (67.1%)] were on admission for more 
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than one week. Table II shows the detailed rates and 
duration of  hospitalization of  the SCA children.
Cost of  hospitalization
As at year 2012, the average cost per hospitalization was 
$132.67 ± $95.24; with a range of  $69.54 – $320.83. 
Hence, the total annual cost of  hospitalizations for the 
73 sickle cell anaemic children was $24,278.37; with a 
mean annual cost of  $332.58 ± $287.59 per child. 
The mean (SD) cost per hospitalization for children 
with vaso-occlusive crisis only was $140.64 ± $91.69, 
ranging from $48.65 to $201.61. For those with 
anaemic crisis only, the cost of  hospitalisation ranged 
from $82.90 to $230.19, with a mean cost of  163.32 
± $74.42. The three children with cerebrovascular 
disease spent a mean cost per hospitalization of  
$621.72 ± $275.86. 
In 137 (74.9%) of  the 183 admissions, the payment 
for care was “out-of-pocket” and in the remaining 46 
(25.1%), NHIS was utilized. Of  those self-sponsored, 
29 (21.2%) had to take a loan to meet the cost of  
admission. From table III which shows the cost 
of  hospitalization by the categories of  payment, 
expenditure on drugs was the highest (38.5%).
Proportion of  family annual income spent on 
hospitalization
The proportion of  annual income spent as total 
expenditure on care ranged from 1.2 to 117%, with 
a mean of  25.1 ± 19.3%. Majority of  the families, 
46 (63.0%), spent <10% of  their annual income on 
hospitalization, and 14 (19.2%), 8 (11.0%) and 5 (6.8%) 
spent 10 - 49%; 50 - 99% and ≥100% of  their annual 
income on hospitalization respectively. Hence, about 
a-third of  the caregivers, 27 (37.0%), spent at least 10% 
of  their annual income for hospitalizing their children 
with SCA.
Effects of  socio-demographic variables, rates 
and duration of  admission on the cost of  
hospitalization
As expected, age and the estimated family monthly 
income were not associated with cost of  care (P = 
0.091 and 0.639 respectively, using one-way ANOVA). 
Also, although females incurred higher mean total cost 
of  care than males, the difference was not significant 
statistically (P = 0.240). Social class was also not 
associated with cost of  care (P = 0.170). (Table IV). 
Table III: Cost of  hospitalization by categories of  payment during the study period
Categories of  
payment
Annual cost  of
Care ( in USD)
% of  the Total 
Annual cost
Average cost of  care per 
hospitalization(in USD)
Investigations 3,847.25 15.8 21.02
Drugs 9,337.49 38.5 51.02
Blood transfusion 2,724.40 11.2 14.89
Transportation 2,372.05 9.8 12.96
Surgeries 1,334.28 5.5 7.29
Others* 4,662.91 19.2 25.48
Total Annual cost 24,278.37 100.0 132.67
NB: *Others refer to costs of  hospital records, nursing charges, accommodation and feeding
On the other hand, the rate of  hospitalization and the length of  hospital stay were positively associated with total hospitalization 
costs. The average total cost for patients with hospital stays of  <7 days was $158.51 less than for patients with hospital stays 
of  ≥7 days (P = 0.026). Similarly, the average total cost for children with more than one admission was $331.21 higher than 
for those with only one admission (P = <0.001). 
Discussion
The management of  SCA consumes a sizeable propor-
tion of  medical resources in most African countries, as 
shown in this study. About 25 percent of  the children 
were admitted on more than three occasions for SCA-
related problems during the study period. The rate of  
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hospitalization for some children was as high as eight 
times in the 12 months study period. Also, we found 
that the average family expenditure per hospitalization 
associated with sickle cell anaemia is substantial and 
that majority of  the caregivers pay this cost at the point 
of  care. As observed by some other researchers,12,13 a 
high level of  expenditure on care of  a particular illness 
may lead to a cut back on other recurrent family expen-
ditures such as feeding, clothing and housing, which in 
turn will affect the quality of  life of  the family. Most 
probably, other children in the family will be severely 
affected because the family income is diverted to the 
care of  their siblings with SCA.  
In this study, the average cost of  care per hospitalization 
was estimated at $132.67 ± 95.24, in a country where 
more than 70 percent of  the population earn less 
than one U.S. dollar per day and spend more than 40 
percent of  their total income to satisfy hunger.14 This 
high cost of  care also reflects what happen in most 
developed economies where the total direct yearly cost 
of  hospitalization for children with SCA is also high.15 
The cost of  care for individuals with SCA also varies with 
the severity of  disease manifestations. A recent study by 
the National Association of  Children’s Hospitals and 
Related Institutions in the United States of  America16 
found that annual charges for children with mild SCA 
were less than $10 000, whereas individuals with severe 
manifestations, including stroke incurred charges 
of  approximately $70 000 per year. In low income 
economies where funds are not readily available for care, 
simple and cost-effective interventions that are geared 
towards limiting the incidence of  severe complications 
of  SCA must be put in place. Such interventions include 
early identification of  SCA patients through newborn 
screening and provision of  comprehensive care such 
as prompt treatment of  acute events and prophylaxis 
against infections, mainly with oral penicillin and 
vaccination against Streptococcus pneumonia.17 
In addition to the high cost of  care, families of  children 
with SCA tend to lose business opportunities and 
absent themselves from work in order to take care of  
the affected child. This further worsens the financial 
difficulties of  the family. In this study, in 21.1 percent 
of  ‘self-sponsored’ admissions, the caregivers had to 
take a loan to meet the cost of  care. Brown et al,18 in 
a recent assessment of  impact of  sickle cell disease 
on carers at the University Teaching Hospital, Ibadan, 
Nigeria, stated that family finances were adversely 
affected in more than half  of  the families, with some 
of  them needing financial help from outside in form 
of  loan to care for their children. 
Periodic estimates of  the cost of  care in children 
with SCA are highly desirable. Firstly, it facilitates the 
assessment of  the value of  new treatments and treatment 
strategies. Cost of  care estimates also allow health care 
payers to plan for the needs of  their patients with SCA. 
Information about the cost of  care in SCA may inform 
the prioritization of  research efforts. Sadly, in Africa 
where the greater burden of  sickle cell syndrome exist, 
such data to estimate the cost of  care in this group of  
children has been scanty. 
Although accurate determination of  family income 
could be subject to recall bias and only 73 children 
with SCA were studied, their rate and duration of  
hospitalization as well as the cost of  care were rather 
too high. To limit these, government must support 
research to develop interventions which can prevent 
sickle cell crisis and limit hospitalization rate. Those 
interventions such as pneumococcal vaccination and 
use of  hydroxyurea undoubtedly have great potential 
for saving health care costs. In sub-Saharan African 
where malaria infection is the leading trigger of  crisis 
in children with SCA, efforts to curtail malaria will 
not only reduce mortality associated with SCA, but 
will also reduce rates and costs of  hospitalization in 
them. The use of  insecticide treated nets, generous and 
regular intake of  fruits and aggresive environmental 
manipulations such as regular clearing of  drainages or 
stagnant water and bush clearing are highly desirable. 
Recently, in a recent experimental study on the influence 
of  lime juice on the severity of  SCA,19 daily intake of  
lime juice for six months was found to limit the rate 
of  bone pain crisis, febrile illness and hospitalization 
in these children. Government should also strengthen 
the NHIS as well as subsidising the cost of  SCA care to 
alleviate the huge financial burden on the family. NHIS 
will increase access of  this group of  children to health 
care and also protect them against the risk of  incurring 
huge and unaffordable medical expenses. National and 
State governments should also develop, implement and 
strengthening SCD policies to enhance care. These 
policies should focus on routine neonatal screening 
for SCD, life-long comprehensive care to minimize 
morbidity and mortality and community education.
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